Yahoo · Oct 1, 2026
McKesson extends CVS deal; shares rise
Investing.com -- McKesson Corporation (NYSE:MCK) shares rose 4.4% Thursday following the announcement of an extended pharmaceutical distribution agreement with CVS Health through June 2032.
NYSE · MCK
McKesson Corporation
Healthcare · Medical - Distribution
$921.67
Down-$11.34 (-1.23%)
Updated Oct 7, 2026, 10:17 PM
SID Score
6.6/10
Composite research score
Smart Money
57/100
Neutral
- Market cap
- 101.96B
- P/E ratio
- 32.2
- Dividend yield
- 0.33%
- 52-week range
- $723.68 – $999.00
- Volume
- 680.46K
- Avg. volume
- 896.08K
Price performance · MCK
MCK price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 6, 2026
MCK closed at $921.67 after 21 trading sessions, up 3.66% for the selected period.
- Last close
- $921.67
- Period change
- +3.66%
- Period low
- $853.81
- Period high
- $921.67
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 6, 2026 | $921.00 | $928.46 | $914.225 | $921.67 | 680.46K |
| Oct 5, 2026 | $905.22 | $922.46 | $900.72 | $915.45 | 697.63K |
| Oct 2, 2026 | $899.02 | $905.55 | $881.40 | $902.28 | 777.05K |
| Oct 1, 2026 | $886.47 | $924.21 | $881.34 | $898.82 | 1.21M |
| Sep 30, 2026 | $862.26 | $866.19 | $847.30 | $853.81 | 696.94K |
| Sep 29, 2026 | $849.29 | $866.44 | $847.285 | $864.82 | 476.91K |
| Sep 28, 2026 | $865.02 | $871.195 | $855.64 | $856.29 | 550.01K |
| Sep 25, 2026 | $865.00 | $871.00 | $858.76 | $866.64 | 452.04K |
| Sep 24, 2026 | $883.02 | $896.60 | $866.59 | $869.36 | 593.54K |
| Sep 23, 2026 | $889.79 | $907.07 | $880.50 | $880.50 | 672.91K |
| Sep 22, 2026 | $891.11 | $897.57 | $882.88 | $891.23 | 935.68K |
| Sep 21, 2026 | $874.79 | $895.34 | $873.3501 | $886.47 | 940.31K |
| Sep 18, 2026 | $872.78 | $881.05 | $864.12 | $874.65 | 2.71M |
| Sep 17, 2026 | $886.11 | $889.81 | $874.73 | $879.57 | 577.26K |
| Sep 16, 2026 | $895.57 | $897.68 | $887.29 | $887.29 | 902.28K |
| Sep 15, 2026 | $902.31 | $907.4975 | $883.59 | $899.56 | 1.15M |
| Sep 14, 2026 | $900.00 | $912.00 | $893.38 | $910.95 | 619.3K |
| Sep 11, 2026 | $888.37 | $893.92 | $874.31 | $881.51 | 888.81K |
| Sep 10, 2026 | $899.77 | $904.83 | $879.24 | $880.86 | 852.97K |
| Sep 9, 2026 | $889.25 | $897.51 | $880.27 | $891.68 | 972.38K |
| Sep 8, 2026 | $891.45 | $904.505 | $877.53 | $889.12 | 747.85K |
Latest MCK news
The latest Smart Investors Daily articles mentioning MCK.
Stock researchCompany · Overview
Company
Market Activity
Research & News
MCK research
Overview
Company profile and research snapshot.
Company profile
McKesson Corp is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- $910.40
- Implied upside
- —
- Analysts
- 14
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 14, 2026 | RBC Capital | Sector Perform | — |
| Aug 19, 2026 | Barclays | Overweight | — |
| Aug 19, 2026 | RBC Capital | Sector Perform | — |
| Aug 11, 2026 | Wells Fargo | Equal-Weight | — |
| Aug 6, 2026 | Evercore ISI Group | Outperform | — |
News briefing
No generated briefing is available yet.
Yahoo · Oct 1, 2026
EPIC Rx Introduces New Wholesale Distribution Options for Member Pharmacies
RICHMOND, Va., October 01, 2026--EPIC Pharmacies, Inc. (EPIC Rx), a nationwide buying group dedicated to supporting and empowering independent pharmacies, today announced an expanded approach to wholesale distribution that provides member pharmacies with greater choice and flexibility in how they purchase medications. As a champion of pharmacy independence, EPIC Rx is putting greater control in the hands of pharmacy owners and operators, allowing them to select the wholesale partner that best al
Yahoo · Oct 1, 2026
McKesson Corporation Extends Pharmaceutical Distribution Agreement with CVS Health
IRVING, Texas, October 01, 2026--McKesson Corporation (NYSE: MCK) announced today that it has signed an agreement in principle to extend its partnership with CVS Health to distribute pharmaceuticals to mail order and specialty pharmacies, retail pharmacies, and distribution centers through June 2032.
Benzinga · Oct 1, 2026
McKesson Reiterates FY27 Adjusted EPS Outlook Range Of $44.20 To $45
McKesson Corporation (NYSE: MCK) announced today it is reaffirming its fiscal year 2027 adjusted EPS guidance of $44.20 to $45.00 and its long-term adjusted EPS growth rate of 13% to 16%. Further updates will be
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
